Cerevel Therapeutics Holdings, Inc.

Ticker

CERE

ISIN

US15678U128

Price

USD 42.10

Change Today

-0.25 / -0.59 %

Price 1 year ago

32.11 / 31.112 %

Market Capitalization

4,222,436,864.00

52 Week Low

20.26

52 Week High

43.27

200 Day Moving Average

33.73

50-day Moving Average

42.18


Price evolution

Yearly Returns


Peers


Peers

Company information

Summary

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I clinical trial for the treatment of substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder; and CVL-047, selective PDE4 inhibitor for the treatment of major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and an LRRK2 inhibitor program to address disease progression in Parkinson's. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Country

United States

Exchange

NCM

Earnings Per Share

-1.712

P/E Ratio

-

Debt/Equity Ratio

19.825

Beta

1.635194

City

Cambridge

Address

222 Jacobs Street

Zip

02141

Ebitda

-279,844,992.00

-

Enterprise to Ebitda

-13.28

Enterprise Value

3,715,131,904.00

Target Price

41.00

Estimated Price

-

Book Value

3.05

Expected Growth

-

Balance sheet

Income statement

Sustainability

Correlation

Company Name Correlation
002007.SZ HUALAN BIOLOGICAL -0.67
600201.SS JINYU BIO-TECHNOLOGY CO LTD -0.63
300147.SZ XIANGXUE PHARMACEU -0.53
DNA Ginkgo Bioworks Holdings, Inc. -0.47
1177.HK SINO BIOPHARM -0.45
002252.SZ S/H RAAS BLOOD PRO -0.43
BLUE bluebird bio, Inc. -0.43
300122.SZ CHONGQING ZHIFEI B -0.42
ATHX Athersys, Inc. -0.40
TMBR Timber Pharmaceuticals, Inc. -0.37
1801.HK INNOVENT BIO -0.30
AKBA Akebia Therapeutics, Inc. -0.22
1530.HK 3SBIO -0.11
1873.HK VIVA BIOTECH -0.10
0775.HK CKLIFE SCIENCES -0.07
300009.SZ ANHUI ANKE BIOTECH -0.06
2269.HK WUXI BIO 0.02
300363.SZ PORTON PHARMA SOLU 0.07
ALPHA.PA PHARNEXT 0.08
300497.SZ JIANGXI FUSHINE PH 0.10
2137.HK BRII-B 0.18
300204.SZ STAIDSON (BEIJING) 0.20
TRX.L TISSUE REGENIX GROUP PLC 0.20
2370.T MEDINET CO LTD 0.42
600866.SS STAR LAKE BIOSCIENCE CO INC Z 0.48
600200.SS JIANGSU WUZHONG PHARMACEUTICAL 0.57
300181.SZ ZHEJIANG JOLLY PHA 0.65
IMU.AX IMUGENE FPO 0.70

Similar companies

Ticker Name City Country Currency Exchange Beta EV/EBITDA Employees Site
ALPHA.PA PHARNEXT Issy-les-Moulineaux France EUR PAR 2.86 -0.65 40 https://www.pharnext.com
1177.HK SINO BIOPHARM Wan Chai Hong Kong HKD HKG 0.48 17.58 25579 https://www.sinobiopharm.com
0775.HK CKLIFE SCIENCES Tai Po Hong Kong HKD HKG 0.40 32.46 1855 https://www.ck-lifesciences.com
DNA Ginkgo Bioworks Holdings, Inc. Boston United States USD NYQ -1.24 641 https://www.ginkgobioworks.com
002252.SZ S/H RAAS BLOOD PRO Shanghai China CNY SHZ 0.21 19.62 2966 https://www.raas-corp.com
002007.SZ HUALAN BIOLOGICAL Xinxiang China CNY SHZ 0.03 19.25 2927 https://www.hualanbio.com
600200.SS JIANGSU WUZHONG PHARMACEUTICAL Suzhou China CNY SHH 0.56 -710.43 https://www.600200.com
600866.SS STAR LAKE BIOSCIENCE CO INC Z Zhaoqing China CNY SHH 0.35 21.35 2608 https://www.starlake.com.cn
TRX.L TISSUE REGENIX GROUP PLC Garforth United Kingdom GBp LSE 1.40 -10.94 79 https://www.tissueregenix.com
2269.HK WUXI BIO Wuxi China HKD HKG 0.91 85.17 9864 https://www.wuxibiologics.com
IMU.AX IMUGENE FPO Sydney Australia AUD ASX 2.28 -30.30 https://www.imugene.com
600201.SS JINYU BIO-TECHNOLOGY CO LTD Hohhot China CNY SHH 0.31 18.76 1580 https://www.jinyu.com.cn
TMBR Timber Pharmaceuticals, Inc. Basking Ridge United States USD ASE 0.19 5 https://www.timberpharma.com
300181.SZ ZHEJIANG JOLLY PHA Huzhou China CNY SHZ 0.10 18.50 2132 https://www.zuoli.com
CLVS Clovis Oncology, Inc. Boulder United States USD NMS 0.49 -3.78 413 https://www.clovisoncology.com
ATHX Athersys, Inc. Cleveland United States USD NCM -1.30 -0.60 104 https://www.athersys.com
VTGN VistaGen Therapeutics, Inc. South San Francisco United States USD NCM 1.06 0.75 36 https://www.vistagen.com
300009.SZ ANHUI ANKE BIOTECH Hefei China CNY SHZ 0.38 19.32 https://www.ankebio.com
300122.SZ CHONGQING ZHIFEI B Chongqing China CNY SHZ 0.77 11.89 4800 https://www.zhifeishengwu.com
2370.T MEDINET CO LTD Tokyo Japan JPY JPX 1.34 -2.69 92 https://www.medinet-inc.co.jp
2137.HK BRII-B Beijing China HKD HKG -5.41 113 https://www.briibio.com
1530.HK 3SBIO Shenyang China HKD HKG 0.84 6.75 5292 https://www.3sbio.com
1801.HK INNOVENT BIO Suzhou China HKD HKG -0.31 -14.04 5568 https://www.innoventbio.com
300497.SZ JIANGXI FUSHINE PH Jingdezhen China CNY SHZ 0.14 35.19 1849 https://www.fushine.cn
300147.SZ XIANGXUE PHARMACEU Guangzhou China CNY SHZ 0.59 374.63 3378 https://www.xphcn.com
BLUE bluebird bio, Inc. Cambridge United States USD NMS 1.38 -0.35 518 https://www.bluebirdbio.com
300204.SZ STAIDSON (BEIJING) Beijing China CNY SHZ 0.16 -27.06 873 https://www.staidson.com
AKBA Akebia Therapeutics, Inc. Cambridge United States USD NGM 1.47 -0.16 426 https://www.akebia.com
1873.HK VIVA BIOTECH Shanghai China HKD HKG 0.95 15.94 2127 https://www.vivabiotech.com.cn
300363.SZ PORTON PHARMA SOLU Chongqing China CNY SHZ -0.36 30.90 4158 https://www.porton.cn
VLON Vallon Pharmaceuticals Inc. Philadelphia United States USD NCM -1.15 -0.24 2 https://www.vallon-pharma.com
SRNE Sorrento Therapeutics, Inc. San Diego United States USD NCM 2.17 -2.59 799 https://www.sorrentotherapeutics.com
NVAX Novavax, Inc. Gaithersburg United States USD NMS 1.58 -2.58 1541 https://www.novavax.com
300759.SZ PHARMARON BEIJING Beijing China CNY SHZ 0.28 49.23 14923 https://www.pharmaron.com
300404.SZ BOJI MEDICAL & TEC Guangzhou China CNY SHZ -0.10 63.41 989 https://www.bojicro.com
RIGL Rigel Pharmaceuticals, Inc. South San Francisco United States USD NMS 1.66 -2.33 165 https://www.rigel.com
688180.SS SHANGHAI JUNSHI BIOSCIENCES CO Shanghai China CNY SHH 0.24 -39.92 2805 https://www.junshipharma.com
600161.SS BEIJING TIANTAN BIOLOGICAL PROD Beijing China CNY SHH 0.02 23.29 3933 https://www.tiantanbio.com
9939.HK KINTOR PHARMA-B Suzhou China HKD HKG -0.77 -5.99 316 https://www.kintor.com.cn
VERU Veru Inc. Miami United States USD NCM -0.41 -41.18 252 https://www.verupharma.com

Funds


Mutual Fund Holders

Social

Dividends

Ratings

News

Earnings

SEC Filings

Options

Indicators

Glossary
Momentum
A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
Inertia
In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
Relative Strength Index (RSI)
A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
Fibonacci's Weighted Moving Average
A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
Williams %R
A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
Relative Volatility Index (RVI)
A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
Commodity Channel Index (CCI)
A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.